Jul. 7 at 4:17 PM
Healthcare stocks are moving higher pre-market, with investors rotating back into the sector.
$XLV +1.2%,
$IBB +1.1%
$VANI gains attention as Novo Nordisk begins an internal evaluation of NPM-139 implant technology, with NVO also trading higher.
$GMAB +3% after the EU approval of Tepkinly combination therapy for follicular lymphoma.
$AGIO +2% following FDA Priority Review for mitapivat in sickle cell disease.
Healthcare is showing renewed momentum as regulatory catalysts and pipeline developments drive interest across biotech and pharma names.
